When does REN.AS report earnings and what matters most?

RELX (REN.AS) announces results on 12 February. Investors should focus on subscription revenue growth, segment margins in Risk and STM, and guidance for Exhibitions recovery. Those items will dictate post-earnings price action.

What are the key valuation metrics for REN.AS stock?

At **€25.14** REN.AS shows **PE 20.95**, price-to-sales **4.16**, EV/EBITDA **13.08**, and free cash flow per share **€1.23**. These metrics imply a premium for recurring data and analytics cash flows.

How does Meyka AI view REN.AS and its outlook?

Meyka AI rates REN.AS **69.67/100 (B, HOLD)** and models a yearly target **€32.37**. The outlook balances steady cash generation and recurring revenue with elevated leverage and valuation risks.

What are short-term trading risks around REN.AS earnings?

Short-term risks include negative guidance, weaker renewals, and Exhibitions volatility. Expect higher intraday volume and swings; current average volume spike suggests elevated attention and potential liquidity-driven moves.

EU Stocks

Earnings 12 Feb: RELX PLC (REN.AS) EURONEXT pre-market, margins in focus

ByHuzaifa Zahoor February 9, 2026February 9, 2026

REN.AS stock opens the pre-market under pressure at €25.14, down -3.01%, with quarterly results due 12 February that could reset investor expectations. Investors will watch revenue growth and margin beats in RELX PLC’s Risk and STM (Scientific, Technical & Medical) segments. On EURONEXT and in Europe the trade will hinge on guidance and subscription renewal trends for content and analytics.